<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01982968</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00049804</org_study_id>
    <secondary_id>1UM1HL119089</secondary_id>
    <nct_id>NCT01982968</nct_id>
  </id_info>
  <brief_title>Treatment of IPF With Laparoscopic Anti-Reflux Surgery</brief_title>
  <acronym>WRAP-IPF</acronym>
  <official_title>Weighing Risks and Benefits of Laparoscopic Anti-Reflux Surgery in Patients With Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will test the hypothesis that treatment with laparoscopic anti-reflux surgery in
      subjects with idiopathic pulmonary fibrosis (IPF) and abnormal gastroesophageal reflux (GER)
      will slow the decline of forced vital capacity (FVC) over 48 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">November 2017</completion_date>
  <primary_completion_date type="Anticipated">November 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Forced vital capacity (FVC)</measure>
    <time_frame>48 weeks</time_frame>
    <description>Decline in FVC (in liters) between enrollment and 48 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acid and non-acid reflux events</measure>
    <time_frame>48 weeks</time_frame>
    <description>Reduction in acid and non-acid reflux events from enrollment to week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety of laparoscopic anti-reflux surgery</measure>
    <time_frame>48 weeks</time_frame>
    <description>Overall safety of laparoscopic anti-reflux surgery in patients with IPF and abnormal GER</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>48 weeks</time_frame>
    <description>Impact of anti-reflux surgery on all-cause mortality from enrollment to 48 weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-elective hospitalization</measure>
    <time_frame>48 weeks</time_frame>
    <description>Impact on non-elective hospitalizations from enrollment to 48 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute exacerbations</measure>
    <time_frame>48 weeks</time_frame>
    <description>Impact on acute exacerbations of IPF from enrollment to week 48.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UCSD SOQB score</measure>
    <time_frame>48 weeks</time_frame>
    <description>Change in UCSD Shortness of Breath Questionnaire score from enrollment to week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SGRQ Score</measure>
    <time_frame>48 weeks</time_frame>
    <description>Change in St. George's Respiratory Questionnaire score from enrollment to week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walk distance</measure>
    <time_frame>48 weeks</time_frame>
    <description>Change in 6-minute walk distance from enrollment to week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cough VAS</measure>
    <time_frame>48 weeks</time_frame>
    <description>Change in cough visual analog scale (VAS) from enrollment to week 48</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HRCT fibrosis score</measure>
    <time_frame>48 weeks</time_frame>
    <description>Change in HRCT fibrosis score from enrollment to week 48</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <condition>Gastroesophageal Reflux</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects to receive standard anti-reflux treatment per clinical discretion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive laparoscopic fundoplication surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <description>Full fundoplication surgery for the treatment of abnormal GER</description>
    <arm_group_label>Surgery</arm_group_label>
    <other_name>Nissen fundoplication</other_name>
    <other_name>Laparoscopic fundoplication</other_name>
    <other_name>Laparoscopic anti-reflux surgery</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed diagnosis of idiopathic pulmonary fibrosis

          -  Abnormal GER on 24-hour pH monitoring (DeMeester score &gt; 14.7)

          -  Able to provide informed consent

          -  Willing to undergo laparoscopic anti-reflux surgery

        Exclusion Criteria:

          -  FVC &lt; 50% predicted

          -  FEV1/FVC ratio &lt; 0.65

          -  Resting room air PaO2 &lt; 60mm Hg

          -  Unable to walk 50 meters on 6 minute walk test

          -  Acute respiratory illness in last 12 weeks

          -  Experimental medication for IPF in last 28 days

          -  Listed for lung transplantation at screening

          -  Unable to safely undergo surgery

          -  History of esophageal / bariatric / gastric surgery

          -  History of cancer (other than non-melanoma skin cancer) in last 3 years

          -  Pregnant at time of screening or enrollment

          -  Unable to obtain pre-authorized approval from a third party payer for surgery and
             related costs

          -  Life expectancy &lt; 48 weeks due to another illness

          -  BMI &gt; 35

          -  Known severe pulmonary hypertension (mean pressure &gt; 35 mm Jg on RHC; RVSP &gt; 50 mm Hg
             on ECHO)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harold R Collard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ganesh Raghu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kevin J Anstrom, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 6, 2013</study_first_submitted>
  <study_first_submitted_qc>November 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2013</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Idiopathic pulmonary fibrosis</keyword>
  <keyword>IPF</keyword>
  <keyword>Gastroesophageal reflux</keyword>
  <keyword>GER</keyword>
  <keyword>GERD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

